ICU Medical Announces First Quarter 2026 Results
ICU Medical, Inc. reported a 12% decline in GAAP revenue for Q1 2026, amounting to $530.2 million, down from $604.7 million in Q1 2025. Despite this, non-GAAP organic revenue increased by 1% when excluding the impact of the IV Solutions divestiture. GAAP net income for the quarter was $30.1 million, compared to a net loss in the previous year’s quarter. The company continues to focus on providing quality and innovation in medical products.
SAN CLEMENTE, Calif., May 07, 2026 (GLOBE NEWSWIRE) — ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2026.